$ANIP Income Statement | Understand Stock

$ANIP

$72.60 -$0.01 (0.01%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net Revenues
Operating Expenses
Cost of sales (excluding depreciation and amortization)
Research and development
Selling, general, and administrative
Depreciation and amortization
Contingent consideration fair value adjustment
Legal settlement expense
Purified Cortrophin Gel pre-launch charges
Loss (gain) on disposal of assets
Restructuring activities
Intangible asset impairment charge
Total Operating Expenses, net
Operating Income
Other Expense, net
Unrealized gain on investment in equity securities
Interest expense, net
Other income (expense), net
Loss on extinguishment of debt
Income (Loss) Before Expense (Benefit) for Income Taxes
Income tax expense (benefit)
Net Income (Loss)
Dividends on Series A Convertible Preferred Stock
Net Income (Loss) Available to Common Shareholders
Basic and Diluted Income (Loss) Per Share:
Basic Income (Loss) Per Share (in dollars per share)
Diluted Income (Loss) Per Share (in dollars per share)
Basic Weighted-Average Shares Outstanding (in shares)
Diluted Weighted-Average Shares Outstanding (in shares)

Comments